Posts by: Joana Carvalho, PhD

Joana Carvalho, PhD

Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.

October 19, 2020October 19, 2020

Tenax Acquires Rights to Oral Levosimendan, Plans Phase 3 Trial in Type 2 PH

News, PH News

Tenax Therapeutics has acquired developmental and commercial rights for North America to an oral formulation of levosimendan, a potential therapy for pulmonary hypertension and heart failure with preserved ejection ... Read more

October 5, 2020October 5, 2020

Imbalance in Gut Bacteria Composition May Play Key Role in PAH

News

An imbalance in the composition of bacteria living in the gut, a phenomenon known as dysbiosis, may play a key role in the onset and progression of pulmonary arterial ... Read more

September 21, 2020September 21, 2020

Moderna, Chiesi Will Collaborate on New RNA-based Therapies for PAH

News, PAH News

Moderna has entered a collaboration agreement with Chiesi Farmaceutici to develop new messenger RNA-based therapies for pulmonary arterial hypertension (PAH). Messenger RNAs (mRNAs) are the molecules that cells use ... Read more

September 2, 2020September 2, 2020

High Mortality Rates Found for Premature Babies With BPD-PH Despite Therapies

News, PH News

Despite current targeted therapies, premature babies with bronchopulmonary dysplasia or BPD — a disease in which the lungs become irritated and fail to develop properly, causing breathing difficulties — ... Read more

August 28, 2020August 28, 2020

Study: Robot-assisted Surgery Lowers Heart Strain, Improves Exercise Capacity in CTEPH Patients

CTEPH News, News

Robot-assisted pulmonary artery denervation (PADN) — a minimally invasive surgical procedure that destroys some of the nerves innervating the pulmonary artery to reduce blood pressure — can lower heart ... Read more

August 24, 2020August 24, 2020

Endovascular Treatment Can Increase Chance of Survival in Newborns With VGAM, Study Finds

News

Endovascular embolization — a minimally invasive surgery that cuts off blood flow from a specific group of blood vessels in the body — can increase the chances of survival ... Read more

August 12, 2020August 14, 2020

Liquida’s LIQ861 Found to Improve Exercise Capacity, Quality of Life in PAH

News, PAH News

LIQ861, Liquidia Technologies’ proprietary inhaled dry powder formulation of the vasodilator treprostinil, improves exercise capacity and quality of life for people with pulmonary arterial hypertension (PAH), according to data ... Read more

July 22, 2020July 30, 2020

Opsumit Can Lower Mortality Risk in PAH Patients, Study Contends

News, PAH News

When used alone or in combination with other therapies, Opsumit (macitentan) can lower the mortality risk in patients with pulmonary arterial hypertension (PAH), a study found. The study, “Changes ... Read more

July 8, 2020July 8, 2020

PH Association Seeks Patient Videos, Photos for its Virtual Fashion Show

News

The Pulmonary Hypertension Association (PHA) is inviting the patient community to participate in its virtual fashion show, set for Aug. 1, as part of its “PHA Connects: Summer PHling.” ... Read more

July 6, 2020July 6, 2020

QuickFire Challenge Launched in Korea to Advance Healthcare Innovations

News

Janssen Korea and Johnson & Johnson Innovation have launched an initiative to help advance breakthrough innovations to improve patient care during the COVID-19 pandemic, including those that can potentially ... Read more

Pin It on Pinterest